| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Towa Pharmaceutical Co., Ltd. Announces Rise In Q1 Bottom Line | 1 | RTTNews | ||
| 26.06. | Adragos Pharma Kawagoe, Towa Pharmaceutical Ink Strategic Supply Pact | 1 | Contract Pharma | ||
| 14.05. | Towa Pharmaceutical Co., Ltd. Announces Decline In Full Year Profit | 1 | RTTNews | ||
| TOWA PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 30.03. | Dividendenbekanntmachungen (30.03.2026) | 22.017 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 77 BANK LTD JP3352000008 113 JPY 0,6124 EUR ACOM CO LTD JP3108600002 10 JPY 0,0542 EUR ADAMAS TRUST INC US6496048405 0,23 USD 0... ► Artikel lesen | |
| 29.09.25 | Dividendenbekanntmachungen (29.09.2025) | 24.363 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1777 EUR ACOM CO LTD JP3108600002 10 JPY 0,0572 EUR ADVANTEST CORPORATION JP3122400009 19... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 49,870 | +0,12 % | DAX vor spannender Woche - und Rekorden? Bayer, Siemens Energy, Commerzbank und Allianz mit ... | Ungeachtet der geopolitischen Krisenherde könnte die überwiegend positiv aufgenommene Berichtssaison der DAX-Konzern auch in der neuen Woche Rückenwind verleihen. Sinkende Ölpreise und starke Quartalszahlen... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 79,33 | 0,00 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| ZHENGYE BIOTECHNOLOGY | 1,890 | 0,00 % | Zhengye Biotechnology regains Nasdaq bid price compliance; shares down | ||
| ETON PHARMACEUTICALS | 44,560 | -0,09 % | Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 | ASN-001 targets the substantially larger population of moderate infantile hemangiomas currently treated off-label with topical timololComplementary product to HEMANGEOL (propranolol hydrochloride)... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 13,880 | -0,04 % | Kazia Therapeutics Limited: Kazia Therapeutics Appoints James Levine as Chief Financial Officer | SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company... ► Artikel lesen | |
| OMNIAB | 3,080 | 0,00 % | OmniAb GAAP EPS of -$0.05 beats by $0.07, revenue of $13.4M beats by $8.71M | ||
| LB PHARMACEUTICALS | 47,960 | -0,08 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Announces $150 Million Private Placement | NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact... ► Artikel lesen | |
| NOVO NORDISK | 40,815 | -0,44 % | Märkte am Morgen: Öl, Bilanzen der Wochen, Palantir, Novo Nordisk/Eli Lilly, Microsoft/Amazon, BYD | Der DAX hat sich in der vergangenen Woche gut geschlagen. Unter dem Strich legte er 2,1 Prozent zu. Am Freitag näherte er sich kurzzeitig seinem Rekordhoch, gab den größten Teil seiner Gewinne allerdings... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,945 | +0,13 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Reaffirms guidance to resubmit Anaphylm (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 14,340 | 0,00 % | Generate Biomedicines, Inc. - 10-Q, Quarterly Report | ||
| PFIZER | 23,005 | -0,56 % | Größter Pharma-Deal ever: AstraZeneca & Bristol Myers: 400-Milliarden-Fusion - die Börse hasst die Idee | © Foto: Michael Nguyen - picture alliance / NurPhotoDer mögliche Zusammenschluss wäre historisch. Doch Anleger sehen vor allem Patentdruck, Integrationsrisiko und die Frage: Warum braucht AstraZeneca... ► Artikel lesen | |
| APNIMED | 26,810 | 0,00 % | Apnimed, Inc.: Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) ("Apnimed"), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization... ► Artikel lesen | |
| JOURNEY MEDICAL | 6,400 | -0,47 % | Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 | ||
| SUNSHINE BIOPHARMA | 1,270 | +3,25 % | Sunshine Biopharma Inc.: Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market | Sunshine Biopharma's Amoxicillin now shipping to Canadian pharmacies in multiple dosages and strengthsLaunch expands Sunshine Biopharma's growing portfolio of essential prescription medicationsGlobal... ► Artikel lesen | |
| KARDIGAN | 20,390 | -0,54 % | Kardigan, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan, Inc. (Nasdaq: KARD) ("Kardigan"), a clinical-stage precision therapeutics company developing medicines that target the root... ► Artikel lesen |